Venlo, the Netherlands 3/29/16; Copenhagen, Denmark 3/29/16—QIAGEN has announced that it plans to submit a conditional voluntary takeover offer to Exiqon shareholders. QIAGEN will offer DKK 18 ($2.70 = DKK 6.67 = $1) per share, a 41.7% premium over Exiqon’s closing price on March 29, or DKK 683 million ($102 million). Publicly held Exiqon provides […]
Palo Alto, CA 3/18/16; Santa Clara, CA 3/20/16; Waltham, MA 3/20/16; Palo Alto, CA 3/21/16; Palo Alto, CA 3/22/16; Waltham, MA 3/22/16; Santa Clara, CA 3/23/16; Santa Clara, CA 3/28/16; Palo Alto, CA 3/28/16; Waltham, MA 3/28/16; Waltham, MA 3/31/16—On March 31, Affymetrix shareholders approved Thermo Fisher Scientific’s offer to acquire the company for $14 […]
Although the use of 2D cellular assays for drug discovery predominates, the adoption of 3D assays is steadily growing. Three-dimensional assays (also known as 3D microtissues) are self-generated clusters of cell colonies. Such assays provide greater physiological and morphological relevance compared to 2D assays, aiming to reduce drug candidate failures and the use of animal […]
Western blotting, also known as immunoblotting, is a technique for detecting proteins. Used since the 1970s, it has become an industry standard for protein detection and characterization. It allows researchers to verify the expression of a specific protein, determine the relative amount of protein present and analyze protein-protein interaction. Western blotting relies on a handful […]
Company Announcements ZEISS announced that fiscal 2015 revenues for the year ending September 30, 2015, for the Research & Quality Technology business, consisting of the Industrial Metrology and Microscopy business groups, increased 11.4% to €1,356 million ($1,559 million) to make up 30% of company revenues. Microscopy sales were below expectations. In January, TESCAN USA appointed […]
Company Announcements SomaLogic established in December 2015 its first continental European SOMAscan Assay Site at VU University Medical Center Amsterdam. Mimetas received $1.6 million in industry funding to develop an organ-on-a-chip model for neurotoxicity. Mimetas will lead a consortium that includes the Institute for Risk Assessment Sciences and Cellular Dynamics. PerkinElmer and EpiCypher collaborated to […]
Company Announcements Berkeley Lights, which is developing nanofluidic biosystems for single-cell analysis, announced in September 2015 that it raised $90 million in funding to date in partnership with Sequoia and Walden Riverwood Ventures. Berkeley Lights announced early access agreements with the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai and the University of […]
Company Announcements For the fiscal half year ending September 2015, Oxford Instruments sales fell 5.8%, down 2.8% organically, to £164.8 million ($253.5 million) (see IBO 11/15/15). Growth was hampered by weak global Industrial Analysis sales within the Industrial Products segment, which fell 7.9% organically. While organic growth for the Nanotechnology Tools segment was marginally lower, […]
Company Announcements AstraZeneca announced in November 2015 a five-year collaboration with Genedata to speed up data sharing. AstraZeneca will share the collaboration platform software with early-stage partners. In January, Schrödinger announced a research collaboration agreement with Pfizer to develop a computational model for predicting key properties relevant to biotherapeutic candidates. Qlucore named Genomax as a […]
Every year, IBO selects three new products at Pittcon that standout among the many product introductions. These three products are distinguished by their innovation, commercial potential and advanced technology. This year’s top products feature capabilities that are the first of their kind. Hitachi High-Technologies’ AeroSurf 1500 SEM One of the drawbacks of EM is that […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
